(S)-1-(AZETIDIN-3-YL)-3-FLUOROPYRROLIDINE 2HCL, 95.0%, 250mg

1-(2-aminoethoxy)-2,3-dichlorobenzene hydrochloride, 2.5g

1-Cinnamoylpiperazine, 96.0%, 2g

Droxidopa>98.0%(HPLC)(T)200mg

(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 95.0%, 250mg

5-Bromo-1,7-naphthyridine-3-carboxylic acid, 98%, 5g

4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-, 100mg

tert-butyl 2-(4-methoxyphenyl)-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate, 25mg

(2R,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

4-Phenylquinoline, 95.0%, 250mg

Table magnifier Magnification 8x. Lens material: plastic. Field of view 30 mm. 10mm/100 reticle. Lens size Ø 30 mm

2-((Difluoromethyl)thio)benzo[d]thiazole, 97%, 250mg

6-Chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-one, 98.0%, 5mg